果冻传媒 of the WeekAMS given the nod by the FDAThe wound-care group received welcome news from the US regulatorSave12 March 2020
NewsG4S earnings-negative on impairmentThe security group registered an earnings loss on a goodwill charge, but the problem is at the margins Save11 March 2020
NewsSpire haunted by clinical issuesThe private hospital group is earnings positive, but malpractice issues lingerSave6 March 2020
NewsHoliday fever with the coronavirusLock-downs and quarantine are a hard sell for tour operatorsSave4 March 2020
NewsHill and Smith expands capacityThe infrastructure engineer has increased capacity as its key markets attempt to remedy years of under-investmentSave4 March 2020
NewsHis Lordship sells as Ocado evolvesThe industry veteran has sold his latest tranche of sharesSave4 March 2020
果冻传媒 of the WeekChi-Med bolsters commercial teamThe bio-pharma group has eight drug candidates in playSave4 March 2020
果冻传媒 of the WeekIMI's second half margin boostThe engineer has been driving efficiencies but there are some issues beyond management's controlSave29 February 2020
NewsReckitt Benckiser suffers 拢5bn impairment Company swings to a net loss of 拢4bn in 2019Save27 February 2020
NewsHikma signals US dealThe pharma group cheered investors with a 16 per cent dividend hike and news of a potentially lucrative US dealSave27 February 2020
